Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal
Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
Read More Healthcare Industry News McKesson to acquire 70% stake in Core Ventures for $2.5bn to expand oncology platform In a strategic move to bolster its presence in community-based oncology care, McKesson Corporation (NYSE: MCK) has signed… byPallavi MadhirajuAugust 27, 2024